http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0050456-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dac022280ec96f54c694eb427655932
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41388940d2fcd984e88fc1254f4dad03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c38806a8c73a7e952b42f718d8838204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0851bf7236519d26a2f3815332f0768
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-81
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
filingDate 2000-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2f5cafd452884f0d406ca1e065d39e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7de66ae164b9a295cc19538184f13be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d134d075ba9c013dcdb4eec3c2a95c1
publicationDate 2000-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0050456-A3
titleOfInvention Covalently bridged insulin dimers
abstract The invention relates to insulin analogues of formula (I), in which X can independently be a branched or unbranched C1-C10-alkyl group, a simply or multiply substituted aryl group, a C1-C10-alkyl group, simply or multiply substituted or unsubstituted O-aryl group, an amino acid or a derivative thereof, or a group of the formula NRR'; R, R' is H, NH2, a branched or unbranched C1-C10-alkyl rest or a simply or multiply substituted or unsubstituted aryl group; and n is 0, 1, 2,... 16. The invention also relates to a medicament containing such insulin analogues, a method for preparing a medicament for the treatment of diabetes and a method for the preparation of insulin analogues.
priorityDate 1999-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9505187-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73940242

Total number of triples: 31.